BACKGROUND: Granulomatous and lymphocytic interstitial lung disease (gl-ILD) is a major cause of morbidity and mortality among patients with common variable immunodeficiency. Corticosteroids are recommended as first-line treatment for gl-ILD, but evidence for their efficacy is lacking. OBJECTIVE: We analyzed the effect of high-dose corticosteroids (≥0.3mg/kg prednisone equivalent) on gl-ILD, measured by high-resolution computed tomography (HRCT) scans, pulmonary function test (PFT) results. METHODS: Patients who had received high-dose corticosteroids but no other immunosuppressive therapy at the time (n=56) and who underwent repeated HRCT scanning or PFT during the retrospective and/or prospective phase of the STILPAD study (n=39) were included in the analysis. Patients without any immunosuppressive treatment were selected as controls (n=23). HRCT scans were blinded, randomized and scored using the Hartman score. Differences between the baseline and follow up HRCT scans and PFT were analyzed. RESULTS: Treatment with high-dose corticosteroids significantly improved HRCT scores and forced vital capacity. Carbon monoxide diffusion capacity significantly improved in both groups. 13/18 patients, for whom extended follow-up data was available, achieved a long-term, maintenance therapy independent remission. All patients with relapse were re-treated with corticosteroids, but only 1/5 responded. Two opportunistic infections were found in the corticosteroid treatment group, while overall infection rate was similar between cohorts. CONCLUSION: Induction therapy with high-dose corticosteroids improved HRCT scans and PFT results of patients with gl-ILD and achieved long-term remission in 42% of patients. It was not associated with major side-effects. Low dose maintenance therapy provided no benefit and efficacy was poor in relapsing disease.
- Smits, B.
- Goldacker, S.
- Seneviratne, S.
- Malphettes, M.
- Longhurst, H.
- Mohamed, O. E.
- Witt-Rautenberg, C.
- Leeman, L.
- Schwaneck, E.
- Raymond, I.
- Meghit, K.
- Uhlmann, A.
- Winterhalter, C.
- van Montfrans, J.
- Klima, M.
- Workman, S.
- Fieschi, C.
- Lorenza, L.
- Boyle, S.
- Onyango-Odera, S.
- Price, S.
- Schmalzing, M.
- Aurillac, V.
- Prasse, A.
- Hartmann, I.
- Meerburg, J. J.
- Kemner-van de Corput, M.
- Tiddens, H.
- Grimbacher, B.
- Kelleher, P.
- Patel, S. Y.
- Korganow, A. S.
- Viallard, J. F.
- Tony, H. P.
- Bethune, C.
- Schulze-Koops, H.
- Witte, T.
- Huissoon, A.
- Baxendale, H.
- Grigoriadou, S.
- Oksenhendler, E.
- Burns, S. O.
- Warnatz, K.
Keywords
- Cvid
- Granulomatous and lymphocytic interstitial lung disease
- Hartmann Score
- corticosteroids
- gl-ILD
- immune dysregulation
- observational trial
- pulmonary function tests
- quality of life